bosentan norameda 125 mg/1 tableta film tableta
providens d.o.o. sarajevo - Бозентан - film tableta - 125 mg/1 tableta - 1 film tableta sadrži: 125 mg bosentana (u obliku bosentan monohidrata)
dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
foster nexthaler 100 µg/1 doza+ 6 µg/1 doza prašak za inhaliranje
providens d.o.o. sarajevo - Беклометазон, formoterol - prašak za inhaliranje - 100 µg/1 doza+ 6 µg/1 doza - 1 doza praška za inhaliranje sadrži: 100 µg beklometazon dipropionat, anhidrid 6 µg formoterol fumarat dihidrat
ursogrix 250 mg tvrde kapsule
as grindeks, krustpils iela 53, riga, latvija - ursodeoksikolatna kiselina - kapsula, tvrda - 250 mg - urbroj: svaka kapsula sadrži 250 mg ursodeoksikolatne kiseline
sunitinib alpha-medical 12,5 mg tvrde kapsule
alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - sunitinibmalat - kapsula, tvrda - urbroj: jedna kapsula sadrži 12,5 mg sunitiniba u obliku sunitinibmalata
sunitinib alpha-medical 25 mg tvrde kapsule
alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - sunitinibmalat - kapsula, tvrda - urbroj: jedna kapsula sadrži 25 mg sunitiniba u obliku sunitinibmalata
sunitinib alpha-medical 50 mg tvrde kapsule
alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - sunitinibmalat - kapsula, tvrda - urbroj: jedna kapsula sadrži 50 mg sunitiniba u obliku sunitinibmalata
sunitinib pliva 12,5 mg tvrde kapsule
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - сунитиниб - kapsula, tvrda - 12,5 mg - urbroj: jedna kapsula sadrži 12,5 mg sunitiniba
sunitinib pliva 25 mg tvrde kapsule
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - сунитиниб - kapsula, tvrda - 25 mg - urbroj: jedna kapsula sadrži 25 mg sunitiniba
sunitinib pliva 37,5 mg tvrde kapsule
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - сунитиниб - kapsula, tvrda - 37,5 mg - urbroj: jedna kapsula sadrži 37,5 mg sunitiniba